Decontamination of surgical instruments from prion proteins: In vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces

Journal of General Virology

Volumn 85, Issue 12, 2004, Pages 3805-3816

  Lemmer, Karin ^a   Mielke, Martin ^a   Pauli, Georg ^a   Beekes, Michael ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; DISINFECTANT AGENT; DODECYL SULFATE SODIUM; PERACETIC ACID; PRION PROTEIN; PROTEINASE K; REAGENT; SODIUM HYDROXIDE; STEEL;

ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; IN VITRO STUDY; INFECTION CONTROL; INFECTION PREVENTION; INSTRUMENT STERILIZATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRION DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; SCRAPIE; SCREENING; SURGICAL EQUIPMENT; WESTERN BLOTTING;

DECONTAMINATION; GUANIDINES; PRPSC PROTEINS; SODIUM HYDROXIDE; SODIUM HYPOCHLORITE; STEEL; SURGICAL INSTRUMENTS; THIOCYANATES; UREA;

ANIMALIA;

EID: 9944261347     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.80346-0     Document Type: Article

References (60)

1. Abschlussbericht der Task Force vCJK (2002). Die Variante der Creutzfeldt-Jakob-Krankheit (vCJK). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 45 376-394.
2. Alper, T., Haig, D. A. & Clarke, M. C. (1966). The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22, 278-284.
3. Alper, T., Cramp, W. A., Haig, D. A. & Clarke, M. C. (1967). Does the agent of scrapie replicate without nucleic acid? Nature 214, 764-766.
4. Appel, T., Wolff, M., von Rheinbaben, F., Heinzel, M. & Riesner, D. (2001). Heat stability of prion rods and recombinant prion protein in water, lipid and lipid-water mixtures. J Gen Virol 82 465-473.
5. Baier, M., Schwarz, A. & Mielke, M. (2004). Activity of an alkaline 'cleaner' in the inactivation of the scrapie agent. J Hosp Infect 57, 80-84.
6. Baldauf, E., Beekes, M. & Diringer, H. (1997). Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord. J Gen Virol 78, 1187-1197.
7. Beekes, M., Baldauf, E., Caßens, S. & 7 other authors (1995). Western blot mapping of disease-specific amyloid in various animal species and humans with transmissible spongiform encephalopathies using a high-yield purification method. J Gen Virol 76, 2567-2576.
8. Beekes, M., Baldauf, E. & Diringer, H. (1996). Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J Gen Virol 77, 1925-1934.
9. Beekes, M., Mielke, M., Pauli, G., Baier, M. & Kurth, R. (2004). Aspects of risk assessment and risk management of nosocomial transmission of classical and variant Creutzfeldt-Jakob disease with special attention to German regulations. In Prions. A Challenge for Science, Medicine and the Public Health System. Contributions to Microbiology, vol. 11, pp. 117-135. Edited by H. F. Rabenau, J. Ciantl & H. W. Doerr. Basel: Karger.
10. Brown, P., Gibbs, C. J., Jr, Amyx, H. L., Kingsbury, D. T., Rohwer, R. G., Sulima, M. P. & Gajdusek, D. C. (1982). Chemical disinfection of Creutzfeldt-Jakob disease. N Engl J Med 306, 1279-1282.
11. Brown, P., Rohwer, R. G. & Gajdusek, D. C. (1986). Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 153, 1145-1148.
12. Brown, P., Preece, M., Brandel, J. P. & 12 other authors (2000). Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55, 1075-1081.
13. Brown, P., Cervenakova, L. & Diringer, H. (2001). Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 137, 5-13.
14. Bruce, M. E., Will, R. G., Ironside, J. W. & 10 other authors (1997). Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501.
15. Bruce, M. E., McConnell, I., Will, R. G. & Ironside, J. W. (2001). Detection of variant Creutzfeldt-Jakob disease infectivity in extra-neural tissues. Lancet 358, 208-209.
16. Cousens, S. N., Linsell, L., Smith, P. G., Chandrakumar, M., Wilesmith, J. W., Knight, R. S., Zeidler, M., Stewart, G. & Will, R. G. (1999). Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 353, 18-21.
17. Ernst, D. R. & Race, R. E. (1993). Comparative analysis of scrapie agent inactivation methods. J Virol Methods 41, 193-202.
18. Flechsig, E., Hegyi, I., Enari, M., Schwarz, P., Collinge, J. & Weissmann, C. (2001). Transmission of scrapie by steel-surface-bound prions. Mol Med 7, 679-684.
19. Glatzel, M., Abela, E., Maissen, M. & Aguzzi, A. (2003). Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349, 1812-1820.
20. Haik, S., Faucheux, B. A., Sazdovitch, V., Privat, N., Kemeny, J. L., Perret-Liaudet, A. & Hauw, J. J. (2003). The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat Med 9, 1121-1123.
21. Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K C., Gowland, I., Collinge, J., Doey, L. J. & Lantos, P. (1997). The same prion strain causes vCJD and BSE. Nature 389, 448-450.
22. Hilton, D. A., Fathers, E., Edwards, P., Ironside, J. W. & Zajicek, J. (1998). Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352, 703-704.
23. Hilton, D. A., Ghani, A. C., Conyers, L., Edwards, P., McCardle, L., Penney, M., Ritchie, D. & Ironside, J. W. (2002). Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 325, 633-634.
24. Hörnlimann, B., Pauli, G., Harbarth, S., Widmer, H.-R. & Simon, D. (2001). Die Prävention von Prionkrankheiten im medizinischen Bereich. In Prionen und Prionkrankheiten, pp. 415-422. Edited by B. Hörnlimann, D. Riesner & H. Kretzschmar. Berlin, New York: de Gruyter.
25. Ironside, J. W. (2000). Pathology of variant Creutzfeldt-Jakob disease. Arch Virol Suppl 16, 143-151.
26. Jendroska, K., Heinzel, F. P., Torchia, M., Stowring, L., Kretzschmar, H. A., Kon, A., Stern, A., Prusiner, S. B. & DeArmond, S. J. (1991). Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 41, 1482-1490.
27. Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M. & Diringer, H. (1987 . Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins 7. J Virol 61, 3688-3693.
28. Kimberlin, R. H., Walker, C. A., Millson, G. C., Taylor, D. M., Robertson, P. A., Tomlinson, A. H. & Dickinson, A. G. (1983 . Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agent. J Neurol Sci 59, 355-369.
29. Köhnlein, J., Schmidt, V., Staffeldt, J. & Werner, H.-P. (2004). Analysis of different test soilings for verification of cleaning performance. Hyg Med 29, 13-19.
30. Sc formation in neuroblastoma cells infected with different prion strains. J Gen Virol 81, 2555-2563.
31. Llewelyn, C. A., Hewitt, P. E., Knight, R. S., Amar, K., Cousens, S., Mackenzie, J. & Will, R. G. (2004). Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 411-412.
32. Manuelidis, L. (1997). Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J Neurovirol 3, 62-65.
33. McKinley, M. P., Bolton, D. C. & Prusiner, S. B. (1983). A protease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62.
34. McLeod, A. H., Murdoch, H., Dickinson, J. & 7 other authors (2004). Proteolytic inactivation of the bovine spongiform encephalopathy agent. Biochem Biophys Res Commun 317, 1165-1170.
35. Prusiner, S. B. (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144.
36. Prusiner, S. B. (1998). Prions. Proc Natl Acad Sci U S A 95, 13363-13383.
37. Prusiner, S. B., Groth, D., Serban, A., Stahl, N. & Gabizon, R. (1993). Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci U S A 90, 2793-2797.
38. Ramasamy, I., Law, M., Collins, S. & Brooke, F. (2003). Organ distribution of prion proteins in variant Creutzfeldt-Jakob disease. Lancet Infect Dis 3, 214-222.
39. Rutala, W. A. & Weber, D. J. (2001). Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization. Clin Infect Dis 32, 1348-1356.
40. Scott, M. R., Will, R., Ironside, J., Nguyen, H. O., Tremblay, P., DeArmond, S. J. & Prusiner, S. B. (1999). Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci U S A 96, 15137-15142.
41. Sehulster, L. M. (2004). Prion inactivation and medical instrument reprocessing: challenges facing healthcare facilities. Infect Control Hosp Epidemiol 25, 276-279.
42. Simon, D. & Pauli, G. (1998). Krankenversorgung und Instrumentensterilisation bei CJK-Patienten und CJK-Verdachtsfällen. Bundesgesundheitsblatt 7, 279-285.
43. Taguchi, F., Tamai, Y., Uchida, K., Kitajima, H., Kojima, H., Kawaguchi, T., Ohtani, Y. & Miura, S. (1991). Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch Virol 119, 297-301.
44. Tateishi, J., Tashima, T. & Kitamoto, T. (1991). Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen. Microbiol Immunol 35, 163-166.
45. Taylor, D. M. (1991). Resistance of the ME7 scrapie agent to peracetic acid. Vet Microbiol 27, 19-24.
46. Taylor, D. M. (1999). inactivation of prions by physical and chemical means. J Hosp Infect 43, S69-S76.
47. Taylor, D. M. (2000). Inactivation of transmissible degenerative encephalopathy agents: a review. Vet J 159, 10-17.
48. Taylor, D. M. (2003). Preventing accidental transmission of human transmissible spongifom encephalopathies. Br Med Bull 66, 293-303.
49. Taylor, D. M. (2004). Resistance of transmissible spongiform encephalopathy agents to decontamination. Contrib Microbiol 11, 136-145.
50. Taylor, D. M., Fraser, H., McConnell, I., Brown, D. A., Brown, K. L., Lamza, K. A. & Smith, G. R. (1994). Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie. Arch Virol 139, 313-326.
51. Taylor, D. M., Brown, J. M., Fernie, K. & McConnell, I. (1997). The effect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol 58, 167-174.
52. Taylor, D. M., Fernie, K., McConnell, I. & Steele, P. J. (1999). Survival of scrapie agent after exposure to sodium dodecyl sulphate and heat. Vet Microbiol 67, 13-16.
53. Sc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 4, 530-533.
54. Sc in muscles of hamsters orally exposed to scrapie. J Clin Invest 113, 1465-1472.
55. Wadsworth, J. D. F., Joiner, S., Hill, A. F., Campbell, T. A., Desbruslais, M., Luthert, P. J. & Collinge, J. (2001). Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180.
56. Wells, G. A., Scott, A. C., Johnson, C. T., Gunning, R. F., Hancock R. D., Jeffrey, M., Dawson, M. & Bradley, R. (1987). A novel progressive spongiform encephalopathy in cattle. Vet Rec 31, 419-420.
57. Will, R. G., Ironside, J. W., Zeidler, M. & 7 other authors (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925.
58. World Health Organization (1999). WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 23-26 March. WHO/ CDS/CSR/APH/2000.3.
59. Yan, Z. X., Stitz, L., Heeg, P., Pfaff, E. & Roth, K. (2004). Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 25, 280-283.
60. Zobeley, E., Flechsig, E., Cozzio, A., Enari, M. & Weissmann, C. (1999). Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5, 240-243.